(CYTR) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Benzinga,
1/4/12)
Sickle cell disease is debilitating to millions of Americans, including Pittsburgh Steelers safety Ryan Clark. Although Clark only has one copy of the sickle cell gene -...(read more)
(Value Investing,
6/19/11)
Cytrx Corporation
Investment Overview
Cytrx, a micro, undervalued biopharmaceutical company, currently has three main high potential drugs in its pipeline. Recently, Bloomberg BusinessWeek highlighted the effectiveness of...(read more)
(Wall Street Sector Selector,
5/19/11)
In another installment of highlighting various investment opportunities, today, I’m going to cover CytRx Corporation (ticker: CYTR). As a biotech guy myself, I’m always interested in up and...(read more)
CytRx (CYTR) Company Overview
There is no analysis for CYTR yet. But you can go to Wikinvest to help create one!
